Free Trial

Aptorum Group (APM) Competitors

Aptorum Group logo
$2.50 +0.17 (+7.30%)
Closing price 08/26/2025 04:00 PM Eastern
Extended Trading
$2.44 -0.06 (-2.20%)
As of 07:41 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

APM vs. PHGE, MIRA, TENX, CASI, CVKD, MDCX, RNTX, TRIB, RVPH, and FBLG

Should you be buying Aptorum Group stock or one of its competitors? The main competitors of Aptorum Group include BiomX (PHGE), MIRA Pharmaceuticals (MIRA), Tenax Therapeutics (TENX), CASI Pharmaceuticals (CASI), Cadrenal Therapeutics (CVKD), Medicus Pharma (MDCX), Rein Therapeutics (RNTX), Trinity Biotech (TRIB), Reviva Pharmaceuticals (RVPH), and FibroBiologics (FBLG). These companies are all part of the "pharmaceutical products" industry.

Aptorum Group vs. Its Competitors

Aptorum Group (NASDAQ:APM) and BiomX (NYSEMKT:PHGE) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, risk, earnings, profitability, analyst recommendations and valuation.

Aptorum Group's return on equity of 0.00% beat BiomX's return on equity.

Company Net Margins Return on Equity Return on Assets
Aptorum GroupN/A N/A N/A
BiomX N/A -127.82%-56.50%

In the previous week, Aptorum Group had 7 more articles in the media than BiomX. MarketBeat recorded 8 mentions for Aptorum Group and 1 mentions for BiomX. Aptorum Group's average media sentiment score of 1.05 beat BiomX's score of 0.00 indicating that Aptorum Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aptorum Group
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BiomX
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Aptorum Group has a beta of -0.1, meaning that its share price is 110% less volatile than the S&P 500. Comparatively, BiomX has a beta of 1.42, meaning that its share price is 42% more volatile than the S&P 500.

BiomX has a consensus price target of $21.00, suggesting a potential upside of 3,711.25%. Given BiomX's stronger consensus rating and higher probable upside, analysts clearly believe BiomX is more favorable than Aptorum Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aptorum Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
BiomX
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

3.8% of Aptorum Group shares are owned by institutional investors. Comparatively, 40.6% of BiomX shares are owned by institutional investors. 64.0% of Aptorum Group shares are owned by company insiders. Comparatively, 1.2% of BiomX shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Aptorum Group has higher revenue and earnings than BiomX.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aptorum Group$430K31.10-$4.27MN/AN/A
BiomXN/AN/A-$28.32M-$1.36-0.41

Summary

Aptorum Group beats BiomX on 7 of the 12 factors compared between the two stocks.

Get Aptorum Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for APM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APM vs. The Competition

MetricAptorum GroupMED IndustryMedical SectorNASDAQ Exchange
Market Cap$12.46M$2.50B$5.72B$9.73B
Dividend YieldN/A1.67%3.95%4.07%
P/E RatioN/A22.5330.3026.09
Price / Sales31.10496.64380.6987.72
Price / CashN/A178.3537.7259.08
Price / Book1.146.469.936.67
Net Income-$4.27M$32.94M$3.27B$265.43M
7 Day Performance96.85%2.46%3.66%3.36%
1 Month Performance38.12%1.01%3.83%0.39%
1 Year Performance-17.22%6.21%34.11%19.43%

Aptorum Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APM
Aptorum Group
0.5328 of 5 stars
$2.50
+7.3%
N/A-17.2%$12.46M$430K0.0030Positive News
Gap Down
PHGE
BiomX
2.0359 of 5 stars
$0.51
-31.1%
$21.00
+4,025.7%
-58.6%$14.81MN/A-0.70120News Coverage
MIRA
MIRA Pharmaceuticals
3.0149 of 5 stars
$1.43
-3.4%
$17.00
+1,088.8%
-34.1%$27.27MN/A-2.922
TENX
Tenax Therapeutics
1.4394 of 5 stars
$5.95
-1.0%
$17.00
+185.7%
+45.0%$27.13MN/A-6.479
CASI
CASI Pharmaceuticals
4.0499 of 5 stars
$2.19
-3.3%
$4.00
+83.1%
-65.3%$27.06M$28.54M-0.86180News Coverage
Gap Down
CVKD
Cadrenal Therapeutics
3.0748 of 5 stars
$13.18
+1.0%
$32.00
+142.9%
+78.6%$27.01MN/A-1.484Positive News
Gap Up
MDCX
Medicus Pharma
2.0396 of 5 stars
$1.97
-1.5%
$23.50
+1,092.9%
N/A$26.73MN/A-1.47N/AGap Up
High Trading Volume
RNTX
Rein Therapeutics
N/A$1.14
+0.9%
N/AN/A$26.28MN/A-0.429Gap Up
TRIB
Trinity Biotech
1.4305 of 5 stars
$1.41
-10.2%
N/A-27.6%$25.63M$61.56M-0.48480
RVPH
Reviva Pharmaceuticals
2.6703 of 5 stars
$0.53
+2.3%
$7.17
+1,249.7%
-48.2%$25.49MN/A-0.825Gap Up
FBLG
FibroBiologics
3.312 of 5 stars
$0.61
-1.8%
$13.00
+2,045.2%
-63.3%$25.39MN/A-1.6810Gap Up

Related Companies and Tools


This page (NASDAQ:APM) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners